Accelerating the development, validation, and translational implementation of digital biomarkers across the EATRIS network and beyond.
Overview
The newly established EATRIS Digital Biomarkers Working Group serves as a community of practice aimed at advancing the research, development, validation, and integration of digital biomarkers within translational medicine
The working group brings together academic researchers, clinicians, bioinformaticians, regulatory experts, and industry partners to foster collaboration and knowledge exchange.
It acts as a platform to promote best practices, identify gaps and opportunities, share lessons learnt and develop strategic approaches for accelerating the adoption of digital biomarkers in clinical research and care, with a particular emphasis on unmet needs in translational science.
Priorities
- Standardisation and validation of digital biomarkers
- Integration into clinical research and regulatory frameworks
- Collaborative use cases
- Networking and funding opportunities to foster partnerships and resource mobilisation
- Capacity building and training across the EATRIS network
Why this matters
Digital biomarkers, derived from sensors, wearables, smartphones, and other digital health technologies, offer continuous, real-world insights into health and disease. To fully realise their potential, the community must address key challenges related to validation and standardisation, data quality and interoperability, privacy and ethical considerations, as well as regulatory pathways, clinical validation, and demonstrated utility.
The EATRIS Digital Biomarkers Working Group serves as a collaborative forum to align on these priorities and develop practical, impactful solutions.
What we do
- Map the landscape of ongoing initiatives and assets across EATRIS nodes
- Co-develop standardised frameworks and multimodal repositories to support validation and benchmarking
- Build cross-disciplinary consortia around high-impact use cases
- Engage with regulators and Health Technology Assessment bodies to clarify evidence expectations
- Offer training and knowledge exchange (webinars, workshops, and clinics)
Funding and collaboration opportunities
We are preparing to leverage Horizon Europe and other EU funding schemes to address strategic barriers and accelerate innovation. Members can co-shape concepts, form consortia, and contribute to coordinated submissions.
Who should join
- Academic and clinical researchers working with digital endpoints
- Biostatisticians, data scientists, and engineers
- Industry professionals developing digital health solutions
- Regulatory, Quality Assurance, Health Technology Assessment and clinical operations experts
Get involved
Participation requests are collected through a short online survey here, where applicants can provide their background, interests, and areas of contribution.
You are welcome to share this invitation with relevant colleagues across the network.
Practical details
- Meeting cadence: Monthly virtual meetings, with ad-hoc topic sprints
- Outputs: Networking and collaborative opportunities, shared resources, shared success and unsuccess stories, lessons learnt, training events, and proposal blueprints
- Governance: Coordinated by the EATRIS Biomarker Platform; scientific leadership drawn from the community
